Par Drugs & Chemicals Ltd EPS
Par Drugs & Chemicals Ltd
NSE: PAR
EPS
Key Highlights
- The Earning per Share of Par Drugs & Chemicals Ltd is ₹ 11.78 as of 06 Oct 26 The earning per share of Par Drugs & Chemicals Ltd changed from ₹ 2.06 to ₹ 3.83 over 9 quarters. This represents a CAGR of 31.74% .
Historical Earning per Share of Par Drugs & Chemicals Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Par Drugs & Chemicals Ltd
Company Fundamentals for Par Drugs & Chemicals Ltd
Market Price of Par Drugs & Chemicals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 06 Oct 2026 | 122.74 |
| 05 Oct 2026 | 125.79 |
| 01 Oct 2026 | 123.95 |
| 30 Sep 2026 | 126.64 |
| 29 Sep 2026 | 125.32 |
| 28 Sep 2026 | 130.05 |
| 25 Sep 2026 | 131.41 |
| 24 Sep 2026 | 131.31 |
| 23 Sep 2026 | 131.92 |
| 22 Sep 2026 | 137.82 |
SWOT Analysis Of Par Drugs & Chemicals Ltd
BlinkX Score for Par Drugs & Chemicals Ltd
Asset Value vs Market Value of Par Drugs & Chemicals Ltd
Market Value
₹ 155
Asset Value
Value addition
1.4 X
₹ 64
* All values are in ₹ crores
Competitive Comparison of EPS
| Company | Market Cap | EPS |
|---|
Par Drugs & Chemicals Ltd | 154.78 | 11.78 |
Sun Pharmaceutical Industries Ltd | 427562 | 52.66 |
Divis Laboratories Ltd | 244572 | 112.23 |
Torrent Pharmaceuticals Ltd | 180871 | 58.66 |
Zydus Lifesciences Ltd | 113566 | 48.95 |
Cipla Ltd | 107770 | 44.3 |
| Company | |
|---|---|
| Par Drugs & Chemicals Ltd | 154.78 |
| Sun Pharmaceutical Industries Ltd | 427562 |
| Divis Laboratories Ltd | 244572 |
| Torrent Pharmaceuticals Ltd | 180871 |
| Zydus Lifesciences Ltd | 113566 |
| Cipla Ltd | 107770 |
Historical Market Cap of Par Drugs & Chemicals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Par Drugs & Chemicals Ltd
Historical Revenue of Par Drugs & Chemicals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Par Drugs & Chemicals Ltd
Historical EBITDA of Par Drugs & Chemicals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Par Drugs & Chemicals Ltd
Historical Net Profit of Par Drugs & Chemicals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Par Drugs & Chemicals Ltd
Dividend Payout Over Time
Par Drugs & Chemicals Ltd News Hub
Par Drugs & Chemicals AGM scheduled
Par Drugs & Chemicals announced that the 25th Annual General Meeting (AGM) of the company will be he
Read more
19 Aug 24
Par Drugs & Chemicals to declare Quarterly Result
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 17 August 2024
Read more
10 Aug 24
Par Drugs & Chemicals standalone net profit rises 2.43% in the June 2024 quarter
Net profit of Par Drugs & Chemicals rose 2.43% to Rs 2.53 crore in the quarter ended June 2024 as ag
Read more
05 Aug 24
Par Drugs & Chemicals to declare Quarterly Result
Par Drugs & Chemicals will hold a meeting of the Board of Directors of the Company on 22 October 202
Read more
14 Oct 24
